Philips and Chinese Institute of Health Sciences join forces in molecular medicine

12 September 2007

Shanghai, China. Royal Philips Electronics and the Chinese Institute of Health Sciences (IHS) have announced an agreement to establish a joint research laboratory within the IHS in Shanghai. The joint laboratory will conduct advanced research in the field of molecular medicine.

The ultimate aim is to create new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment. Early diagnosis and personalized treatment will lead to increased comfort and better outcomes for patients. As part of this unique collaboration, Philips intends to locate a team of its own scientists at the joint research laboratory.

“This agreement to set up a joint research laboratory with the IHS in China is a prime example of the Open Innovation approach that Philips is taking in order to bring the many benefits of molecular medicine into patient care.” says Rick Harwig, CTO of Royal Philips Electronics.

The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS) and is also affiliated to the Shanghai Jiao Tong University School of Medicine.

“This collaboration will give us access to Philips’ global research organization, especially the European laboratories, and should serve as a good example for further European collaborations,” said Professor Rongxing Gan, Vice President of SIBS. “The combination of our expertise in translational biomedical research and Philips’ expertise in advanced medical instrumentation will definitely accelerate the development of new healthcare solutions for the Chinese people as well as people around the world.”

To top

Save this page on

To top